Persephone Borrow1. 1. Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. persephone.borrow@ndm.ox.ac.uk
Abstract
PURPOSE OF REVIEW: Acute HIV-1 infection (AHI) is composed of the eclipse phase, during which the transmitted virus struggles to avoid eradication and achieve amplification/spread; the expansion phase when virus disseminates and undergoes exponential replication associated with extensive CD4⁺ T-cell destruction; and the containment phase when set-point levels of viremia and immune activation are established. The importance of interactions between HIV-1 and innate responses in determining events throughout AHI is increasingly recognized, and is reviewed here. RECENT FINDINGS: During the eclipse phase, HIV-1 subverts dendritic cell functions to promote its replication at mucosal sites and employs multiple strategies to minimize control by type 1 interferons. Systemic virus dissemination is associated with widespread activation of innate responses which fuels HIV-1 replication. To minimize the protective effects of innate responses, HIV-1 resists control by natural killer cells and may impair innate regulation of adaptive responses. Innate responses remain chronically activated after HIV-1 containment which is thought to drive HIV-1 pathogenesis. SUMMARY: Innate responses are pivotal determinants of events at all stages of AHI. Increased understanding of mechanisms involved in innate control of HIV-1 and pathways regulating innate activation during HIV-1 infection could facilitate development of novel approaches to combating this infection.
PURPOSE OF REVIEW: Acute HIV-1 infection (AHI) is composed of the eclipse phase, during which the transmitted virus struggles to avoid eradication and achieve amplification/spread; the expansion phase when virus disseminates and undergoes exponential replication associated with extensive CD4⁺ T-cell destruction; and the containment phase when set-point levels of viremia and immune activation are established. The importance of interactions between HIV-1 and innate responses in determining events throughout AHI is increasingly recognized, and is reviewed here. RECENT FINDINGS: During the eclipse phase, HIV-1 subverts dendritic cell functions to promote its replication at mucosal sites and employs multiple strategies to minimize control by type 1 interferons. Systemic virus dissemination is associated with widespread activation of innate responses which fuels HIV-1 replication. To minimize the protective effects of innate responses, HIV-1 resists control by natural killer cells and may impair innate regulation of adaptive responses. Innate responses remain chronically activated after HIV-1 containment which is thought to drive HIV-1 pathogenesis. SUMMARY: Innate responses are pivotal determinants of events at all stages of AHI. Increased understanding of mechanisms involved in innate control of HIV-1 and pathways regulating innate activation during HIV-1 infection could facilitate development of novel approaches to combating this infection.
Authors: Qingsheng Li; Anthony J Smith; Timothy W Schacker; John V Carlis; Lijie Duan; Cavan S Reilly; Ashley T Haase Journal: J Immunol Date: 2009-07-13 Impact factor: 5.422
Authors: Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow Journal: J Virol Date: 2009-01-28 Impact factor: 5.103
Authors: Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase Journal: Nature Date: 2009-03-04 Impact factor: 49.962
Authors: Galit Alter; Suzannah Rihn; Katharine Walter; Anne Nolting; Maureen Martin; Eric S Rosenberg; Jeffrey S Miller; Mary Carrington; Marcus Altfeld Journal: J Virol Date: 2009-04-22 Impact factor: 5.103
Authors: Yufei Wang; Lesley A Bergmeier; Richard Stebbings; Thomas Seidl; Trevor Whittall; Mahavir Singh; Neil Berry; Neil Almond; Thomas Lehner Journal: Vaccine Date: 2008-12-11 Impact factor: 3.641
Authors: Emma L Turnbull; MaiLee Wong; Shuyi Wang; Xiping Wei; Nicola A Jones; Karen E Conrod; Diana Aldam; Jo Turner; Pierre Pellegrino; Brandon F Keele; Ian Williams; George M Shaw; Persephone Borrow Journal: J Immunol Date: 2009-06-01 Impact factor: 5.422
Authors: Sharon Lederer; David Favre; Kathie-Anne Walters; Sean Proll; Bittoo Kanwar; Zeljka Kasakow; Carole R Baskin; Robert Palermo; Joseph M McCune; Michael G Katze Journal: PLoS Pathog Date: 2009-02-13 Impact factor: 6.823
Authors: Nilu Goonetilleke; Michael K P Liu; Jesus F Salazar-Gonzalez; Guido Ferrari; Elena Giorgi; Vitaly V Ganusov; Brandon F Keele; Gerald H Learn; Emma L Turnbull; Maria G Salazar; Kent J Weinhold; Stephen Moore; Norman Letvin; Barton F Haynes; Myron S Cohen; Peter Hraber; Tanmoy Bhattacharya; Persephone Borrow; Alan S Perelson; Beatrice H Hahn; George M Shaw; Bette T Korber; Andrew J McMichael Journal: J Exp Med Date: 2009-06-01 Impact factor: 14.307
Authors: Agnieszka Kielczewska; Michal Pyzik; Tianhe Sun; Astrid Krmpotic; Melissa B Lodoen; Michael W Munks; Marina Babic; Ann B Hill; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier; Silvia M Vidal Journal: J Exp Med Date: 2009-03-02 Impact factor: 14.307
Authors: Christopher W Peterson; Kevin G Haworth; Patricia Polacino; Meei-Li Huang; Craig Sykes; Willimark M Obenza; Andrea C Repetto; Angela Kashuba; Roger Bumgarner; Stephen C DeRosa; Ann E Woolfrey; Keith R Jerome; James I Mullins; Shiu-Lok Hu; Hans-Peter Kiem Journal: AIDS Date: 2015-08-24 Impact factor: 4.177
Authors: Fredrik Barrenas; Robert E Palermo; Brian Agricola; Michael B Agy; Lauri Aicher; Victoria Carter; Leon Flanary; Richard R Green; Randy McLain; Qingsheng Li; Wuxun Lu; Robert Murnane; Xinxia Peng; Matthew J Thomas; Jeffrey M Weiss; David M Anderson; Michael G Katze Journal: J Virol Date: 2014-05-07 Impact factor: 5.103